Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Unit for Genetic & Epidemiological Research on Neurological Disorders, |
RCV000516023 | SCV000574484 | uncertain significance | Hereditary spastic paraplegia | 2017-03-07 | criteria provided, single submitter | research | |
Gene |
RCV000645370 | SCV000713914 | likely benign | not provided | 2023-06-18 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV001085955 | SCV000767115 | likely benign | Spastic ataxia 2 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000645370 | SCV001151168 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000516023 | SCV002105314 | likely benign | Hereditary spastic paraplegia | 2020-11-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915341 | SCV004734496 | likely benign | KIF1C-related disorder | 2022-02-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |